Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. The company is headquartered in Melbourne, Victoria and currently employs 58 full-time employees. The firm is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The firm offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The firm has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The firm's segments include EasyDNA and AffinityDNA. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses.
Follow-Up Questions
What is the price performance of GNTLF stock?
The current price of GNTLF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Genetic Technologies Ltd?
Genetic Technologies Ltd belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Genetic Technologies Ltd market cap?
Genetic Technologies Ltd's current market cap is $0
